Opus Genetics (IRD) FCF Margin (2020 - 2026)

Opus Genetics (IRD) has 7 years of FCF Margin data on file, last reported at 590.03% in Q1 2026.

• On a quarterly basis, FCF Margin fell 38422.0% year-over-year to 590.03% in Q1 2026; TTM through Mar 2026 was 325.34%, a 11398.0% decrease from a year earlier, with the FY2025 full-year figure at 248.33%, down 1565.0% from the prior year.
• FCF Margin for Q1 2026 stood at 590.03%, down from 254.41% in the prior quarter.
• Over the last five years, FCF Margin for IRD reached as high as 268.95% in Q4 2023 and fell as low as 655.76% in Q2 2024.
• Historically, FCF Margin has averaged 197.67% across 5 years, with a median of 202.89% in 2025.
• Across the five-year window, FCF Margin plunged 68267 bps in 2024 and jumped 29944 bps in 2025, its largest moves.
• Year by year, FCF Margin stood at 72.25% in 2022, then surged by 272 bps to 268.95% in 2023, then plunged by 164 bps to 172.9% in 2024, then slumped by 47 bps to 254.41% in 2025, then slumped by 132 bps to 590.03% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 590.03% in Q1 2026, 254.41% in Q4 2025, and 199.97% in Q3 2025.